The main business activity of Trigon Property Development AS is real estate development. As at 31.12.2025, AS Trigon Property Development owned one development project with an area of 13.2 hectares in the City of Pärnu, Estonia. A commercial, industrial and logistics park is planned on this area. The Company’s objective is to find companies willing to bring their business activities (industry, logistics) to the development project area of AS Trigon Property Development in Pärnu, which would add value to the land plots owned by the Company. As the main purpose of the company is to sell existing land plots, investment property was recognized as inventories. In the third quarter of 2024, a 0.09-hectare transportation purpose land was sold for 31,920 euros (excluding VAT). In the fourth quarter of 2024, a 0.70-hectare property was sold for...

VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) today reported the Company’s consolidated interim financial results for the first quarter ended December 31, 2025. All values in thousands and denoted in CAD unless otherwise stated.Reported revenue for Q1 2026 of $1,600, representing an increase of $423 relative to the comparable period in the prior year due to large-scale machine sales and increased royalties. During the period, the company commissioned one large-scale machine and completed the fabrication of two large-scale machines on contract. Reported royalties, excluding exclusivity payments (“Base Royalties”), for Q1 2026 of $500, an increase of $75, or 18% relative to the comparable period in the prior year. Reported total royalty...

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on senior housing and outpatient medical facilities, today announced results for the fourth quarter and full year ended December 31, 2025. Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with the exceptional internal growth of our senior housing portfolio and the steady performance of our outpatient medical portfolio in 2025. We believe the fundamentals within the healthcare real estate industry, especially the senior housing sector, remain robust. We are excited about the year ahead and are committed to delivering strong performance across our business.” Financial Performance and Other Highlights Fourth...

REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) — Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2025 after the close of trading on Wednesday, March 4, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast of the event will be available on the “Investors” section of the Pulmonx website at https://investors.pulmonx.com/. About Pulmonx CorporationPulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr® Endobronchial Valve, Chartis® Pulmonary Assessment System, LungTraX™ Platform,...

MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025. For the quarter, the Company reported net sales of $263.6 million, net earnings of $39.2 million, adjusted EBITDA(a) of $67.9 million, and free cash flow(a) of $51.2 million. For the full year 2025, the Company reported net sales of $1.037 billion, net earnings of $154.8 million, adjusted EBITDA of $274.9 million, and free cash flow of $173.6 million. Ted Harris, Chairman, President, and CEO of Balchem said, “In the fourth quarter, Balchem’s strong growth trajectory continued. We delivered record fourth quarter net sales and adjusted EBITDA, with top and bottom line growth year over year in each of our three segments, driven by ongoing progress...

MONACO, Feb. 20, 2026 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (“Costamare Bulkers” or the “Company”) (NYSE: CMDB) today reported unaudited financial results for the fourth quarter (“Q4 2025”) and year ended December 31, 2025. This earnings release focuses on the financial results and management’s discussion and analysis for the three-month period ended December 31, 2025, reflecting the Company’s performance during its second full quarter as an independent, publicly traded company. Costamare Bulkers had no operating activity during the year ended December 31, 2024 and remained a wholly-owned subsidiary of Costamare Inc. (“Costamare”), a New York Stock Exchange (“NYSE”) listed company, until May 6, 2025, when it became an independent, publicly traded company on NYSE through a spin-off from Costamare. Costamare Bulkers...

Three Month ResultsNet revenues were $595.9 million Net income was $154.7 million Adjusted EBITDA was $288.9 millionTwelve Month ResultsNet revenues were $2.27 billion Net income was $593.1 million Adjusted EBITDA was $1.06 billionBATON ROUGE, La., Feb. 20, 2026 (GLOBE NEWSWIRE) — Lamar Advertising Company (the “Company” or “Lamar”) (Nasdaq: LAMR), a leading owner and operator of outdoor advertising and logo sign displays, announces the Company’s operating results for the fourth quarter and year ended December 31, 2025. “We ended 2025 with encouraging sales momentum, with growth in both local and national in the fourth quarter, even with a tough political comp,” chief executive Sean Reilly said. “That strength continued into 2026, and pacings for the balance of the year remain promising....

Today SSCP Lager Bidco AB (publ) published an interim report for the fourth quarter, the report can be downloaded on www.logent.se or via the link below. For more information, please contact:Andrzej Kulik, CFO, telephone number: +46 738 15 67 00, andrzej.kulik@logent.se or Joel Engström, CEO, telephone number: +46 734 36 36 29, joel.engstrom@logent.se This press release was published on 20-02-2026 at 08:30 CET/CEST This information is of the type that SSCP Lager BidCo AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation, the Swedish Securities Markets Act and the Swedish Financial Instruments Trading Act. The information was submitted for publication through the agency of the contact persons set out above, on 20-02-2026 at 08:30 CET/CEST. About Logent GroupLogent is a comprehensive and independent logistics partner,...

2025 a disappointment, expected to go back to earnings growth in the first quarter 2026  October 1 – December 31, 2025Net sales amounted to MSEK 710 (796). Currency adjusted growth was –1%, where of –5% was organic. EBITA decreased 37% to MSEK 86 (136). EBITA margin was 12.1 (17.0)%. Profit after tax decreased 34% to MSEK 55 (84). Earnings per share decreased 34% to SEK 2.84 (4.30). Following changes in US tax legislation during 2025, BTS’s North American operations have gained expanded and partially retroactive tax deduction possibilities. These changes have had a significant positive impact on the reported income tax for the year which decreased by approximately MSEK 14, with full impact in the fourth quarter.January 1 – December 31, 2025Net sales amounted to MSEK 2,703 (2,802). Currency adjusted growth was 3%, where of –1% was...

2025 Full-Year ResultsPress release – Paris, February 20, 2026 at 7:30am CET 2025: Another year of strong deliveryFY 2025 sales of €27,283m up +4.5% on a like-for-like (LFL) basis, with volume/mix up +2.7%, and price up +1.8% Q4 sales up +4.7% LFL, driven again by strong volume/mix, up +2.5%, and price up +2.1%Sustained momentum in Europe, driven by continued progress in EDP and solid performance in Adult Medical Nutrition and Waters Soft Q4 performance in North America, despite sustained momentum in High Protein and a solid Specialized Nutrition performance Closing a year of exceptional performance in China, North Asia & Oceania with strong Q4 in Specialized Nutrition and EDPRecurring operating margin up +44 basis points (bps) at 13.4% driven by further improvement in margin from operations while continuing to reinvest...